Home > Products > Pharmaceutical R&D Materials > Heterocyclic Building Blocks > 1-(Benzyloxycarbonyl)azetidine-3-carboxylicacid
1-(Benzyloxycarbonyl)azetidine-3-carboxylicacid structure, CAS 97628-92-7

1-(Benzyloxycarbonyl)azetidine-3-carboxylicacid

CAS Number97628-92-7

Synonyms1-[(Benzyloxy)carbonyl]-3-azetidinecarboxylic acid; 1,3-Azetidinedicarboxylic acid, 1-(phenylmethyl) ester; 1-phenylmethoxycarbonylazetidine-3-carboxylic acid

Molecular FormulaC12H13NO4

Molecular Weight235.236

Purity

Density1.4±0.1 g/cm3

Boiling Point421.2±45.0 °C at 760 mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9083727 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 97628-92-7 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number97628-92-7
Catalog No.2A-9083727
Chinese Name1-(苄氧基羰基)氮杂丁烷-3-羧酸
Synonyms1-[(Benzyloxy)carbonyl]-3-azetidinecarboxylic acid; 1,3-Azetidinedicarboxylic acid, 1-(phenylmethyl) ester; 1-phenylmethoxycarbonylazetidine-3-carboxylic acid
Molecular FormulaC12H13NO4
Molecular Weight235.236
Density1.4±0.1 g/cm3
Boiling Point421.2±45.0 °C at 760 mmHg
Storage Condition2-8°C
Application1-Cbz-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-azetidine-3-carboxylic acid is also a PROTAC linker based on an alkyl ch
HTC2933990090
SMILESO=C(O)C1CN(C(=O)OCc2ccccc2)C1
InChI KeyPVJPBKZGIUAESY-UHFFFAOYSA-N
MSDSmsds/83727_1_97628_92_7.pdf
Bioactivity1-Cbz-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1] Related Catalog Research Areas >> Cancer Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker Signaling Pathways >> PROTAC >> PROTAC Linker Target Non-cleavable In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. References [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. [2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. Chemical & Physical Properties Density 1.4±0.1 g/cm3 Boiling Point 421.2±45.0 °C at 760 mmHg Molecular Formula C12H13NO4 Molecular Weight 235.236 Flash Point 208.5±28.7 °C Exact Mass 235.084457 PSA 66.84000 LogP 0.88 Vapour Pressure 0.0±1.1 mmHg at 25°C Index of Refraction 1.599 InChIKey PVJPBKZGIUAESY-UHFFFAOYSA-N SMILES O=C(O)C1CN(C(=O)OCc2ccccc2)C1 Storage condition 2-8°C
Use of1-Cbz-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1] Properties Name 1-Cbz-Azetidine-3-carboxylic acid Synonym More Synonyms Biological Activity Description 1-Cbz-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1] Related Catalog Research Areas >> Cancer Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker Signaling Pathways >> PROTAC >> PROTAC Linker Non-cleavable In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. References [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. [2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. Chemical & Physical Properties Molecular Formula C12H13NO4 Exact Mass 235.084457 PSA 66.84000 Index of Refraction 1.599 InChIKey PVJPBKZGIUAESY-UHFFFAOYSA-N
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Related Products in Heterocyclic Building Blocks
4-Chloro-3-methoxypyridine96628-70-52A-9083707
4,5,6,7-Tetrafluoroindole-3-carboxaldehyde30683-38-62A-9083708
6-Bromo-3-methylquinoline97041-63-92A-9083723
4-Hydroxy-6-methylquinoline97545-52-32A-9083725
3-Bromo-5-(3-TrifluoroMethylphenyl)pyridine975589-94-32A-9083726
5-Methylpyrazine-2-carbonitrile98006-91-82A-9083749
4-Oxoazetidine-2-carboxylicacid98019-65-92A-9083751
2-Hydroxy-3-amino-5-chloropyridine98027-36-22A-9083753
4-Bromo-2,5-dichloropyridine98027-80-72A-9083755
Methyl6-chloro-1H-indole-2-carboxylate98081-84-62A-9083756
Browse all Heterocyclic Building Blocks products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA